Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06094088
Other study ID # 2023p001916
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date April 1, 2024
Est. completion date December 1, 2026

Study information

Verified date March 2024
Source Massachusetts General Hospital
Contact Maren Nyer, PhD
Phone 617-726-8895
Email mnyer@mgh.harvard.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will examine how doing heated yoga or non-heated yoga affects depression.


Description:

The purpose of this study is to investigate the effects of heated and non-heated yoga on depressive symptoms. Previous research trials using heated and non-heated yoga interventions have shown promising results for reducing depression and its related outcomes. However, no studies have directly compared the effects of heated vs. non-heated yoga for depression. The researchers aim to address this gap by conducting a non-inferiority trial comparing heated yoga and non-heated yoga interventions to improve depressive symptoms. Both the heated and non-heated yoga interventions will be conducted in-person by certified yoga instructors. Eligible participants will be adults who do not regularly practice yoga or meditation and are experiencing moderate levels of depression. Assessments will be conducted at baseline, mid-treatment, post-treatment, and follow-up using a secure data capture system.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 120
Est. completion date December 1, 2026
Est. primary completion date September 1, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: 1. adults (=18 years old) 2. provide informed consent 3. are able to read and understand English 4. PHQ-9 score between 10-20, indicating moderate but not severe depressive symptom severity (27) Exclusion Criteria: 1. older adults (> 65 years old) 2. have had a bone fracture or joint surgery in the past 6 months 3. are unable to walk 4. have severe heart failure or lung disease 5. participants endorse an item on the revised Physical Activity Readiness Questionnaire (PAR-Q+) and do not have approval from their treating physician (we will check in with treating physician in the event that participants endorse any item on the PAR-Q+) 6. participants must have a physician responsible for their medical care 7. are pregnant or planning to become pregnant 8. no more than 6 yoga classes in the past 6 months 9. have active suicidal thinking (i.e., PHQ-9 item 9 =1) 10. report manic symptoms (Altman Self-Rating Mania Scale score = 6 (28)) 11. are on medications that make dehydration more likely (e.g., stimulants, lithium, antipsychotics) 12. active eating disorders or substance use disorders within the past 12 months 13. antidepressant or psychiatric medications that are initiated less than 8 weeks or a dose change less than 4 weeks prior to screening visit 14. psychotherapy that has been initiated within the past 3 months 15. willingness to keep psychiatric medications and psychotherapy stable throughout the course of the study 16. psychiatric hospitalization within the past year 17. diagnosed with any neurological disorders that would impact participation or make participation unsafe 18. are not currently in any active ketamine, ECT, or TMS 19. are unable to follow the study procedures (e.g., not able to travel to the heated or non-heated yoga studios)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Heated Yoga
Heated yoga described in arm/group description
Non-Heated Yoga
Non-heated yoga described in arm/group description

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Massachusetts General Hospital Tiny Blue Dot Foundation

Outcome

Type Measure Description Time frame Safety issue
Primary Patient Health Questionnaire-9 (PHQ-9) This measure is a 9-item self-report questionnaire that is widely used to assess depression symptom severity. PHQ-9 scores range from 0 to 27. A PHQ-9 score =10 has a sensitivity of 88% and a specificity of 88% for major depression. PHQ-9 scores of 5, 10, 15, and 20 represented mild, moderate, moderately severe, and severe depression, respectively. Weeks 0, 4, 8, and 20
Secondary The World Health Organization-5 Well-Being Index (WHO-5) This measure is a 5-item self-report questionnaire with positively-worded statements related to positive mood, vitality, and general interest over the prior two weeks. The WHO-5 is reliable, has shown strong construct validity as a measure of general quality of life, and is sensitive to change. The WHO-5 has a score range of 0 to 25, with higher scores indicating better wellbeing. Weeks 0, 4, 8, and 20
Secondary Patient Reported Outcomes Measurement Information System-29 (PROMIS-29) This measure has seven health domains (physical function, fatigue, pain interference, depressive symptoms, anxiety, social functioning, sleep disturbance). The scale includes four items per domain, each scored from 1 to 5. The scale also includes one question at the end about pain intensity, which is scored from 0 to 10. The possible score for each domain ranges from 4 to 20 and the total possible score for the entire measure ranges from 28 to150. Higher scores indicate poorer outcomes. Weeks 0, 4, 8, and 20
Secondary Ruminative Responses Scale (RRS) This measure is a 22-item questionnaire, commonly used to assess rumination. Items are scored from 1 to 4, the scale has a possible range of 22 to 88, and higher scores indicate poorer outcomes (i.e. higher rumination). Weeks 0, 4, 8, and 20
Secondary The Five Facet Mindfulness Questionnaire (FFMQ-15) A self-report instrument that measures mindfulness; derived from factor analytic study of five independent mindfulness questionnaires. The scale contains 39 items, split into five domains (Observing, Describing, Acting with Awareness, Nonjudging, Nonreactivity), with each item being rated from 1 to 5. Some items are reverse coded. Total FFMQ scores range from 39 to 195, with greater scores indicating better outcomes (i.e. greater mindfulness). Weeks 0, 4, 8, and 20
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT04977232 - Adjunctive Game Intervention for Anhedonia in MDD Patients N/A
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Completed NCT04476446 - An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives Phase 3
Recruiting NCT02783430 - Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease Phase 2/Phase 3
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT04598165 - Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Completed NCT05588622 - Meru Health Program for Cancer Patients With Depression and Anxiety N/A
Recruiting NCT05234476 - Behavioral Activation Plus Savoring for University Students N/A
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Enrolling by invitation NCT03276585 - Night in Japan Home Sleep Monitoring Study
Terminated NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A